(DumbMoney.)

Explore the latest updates and key analyses on companies, markets, and industry trends.


Quantum Si Investor & Analyst Day Summary

Quantum Si (QSI) | November 19, 2025

By Liam Parker

image

Quantum Si hosted an Investor & Analyst Day on November 19, 2025, focusing on Proteus and the complexities of the proteome.

The presentations covered Proteus Program updates, Proteoform analysis solutions, and the road to Proteus launch.

The company highlighted the importance of Proteins in various industries and the challenges in proteome research.

Proteus Program Update

The Proteus Program showcased next-generation architecture and innovative technologies to advance protein analysis.

Path to Detecting All 20 Amino Acids

Quantum Si discussed their approach to detecting all 20 amino acids, a crucial aspect of proteomics research.

Importance of Proteoforms

Proteoforms play a significant role in understanding diseases, including variations like single amino acid variants, enhancing disease understanding.

Challenges in Proteomics

Specialized platforms with high capital costs limit widespread adoption in proteomics beyond core labs, posing a barrier to research advancement.

Role of Proteus in Proteomics

The Proteus platform aims to democratize proteomics, enabling deep protein analysis with automation and affordability, expanding the field.

  • Proteoform analysis extends to various disease areas with unique proteins, highlighting the complexity and depth of proteomics research.
  • Specialized platforms in proteomics come with high costs, hindering broader adoption and limiting advancements outside core labs.
  • Proteus promises to revolutionize proteomics by simplifying workflows, increasing throughput, and making deep protein analysis accessible to any lab anywhere.

Quantum Si's focus on advancing proteomics through Proteus and innovative technologies demonstrates a commitment to democratizing protein analysis and driving advancements in biological research.